Huisheng Biotech Pharmaceutical

Manufacturer of APIs, & intermediates as well as finished products

placeHangzhou, Zhejiang, China calendar_todayFounded 2004 language hsbiopharm.com

Social engagement

Social engagement: 216 social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

4 Jun 2026
Expansion
Shangdong, China
8 May 2026
Event
CPHI & PMEC China 2026
30 Apr 2026
Product launch
Orforglipron Hemicalcium Hydrate (LY3502970)
Coming soon